Neuropsychotropic Drug Therapy 2021 | COVID, Chronic Stress and Trauma

Neuropsychotropic Drug Therapy 2021

COVID, Chronic Stress and Trauma: How Looking For and Treating Hyperarousal Can Help Us Through

On-Demand Program

Speaker

Rebecca Hendrickson, MD, PhD
Psychiatrist, VA PTSD Outpatient Clinic; Research Investigator, VA Northwest Mental Illness Research, Education and Clinical Center; Acting Assistant Professor, Psychiatry and Behavioral Sciences. University of Washington, Seattle

Target Audience

For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be better able to:

1. Know how and why to look for hyperarousal symptoms after chronic stress and trauma.
2. Identify pharmacologic treatment options for treating hyperarousal symptoms.
3. Know how to use at least one pharmacologic treatment option for treating hyperarousal symptoms.